Apolipoprotein E pathology in vascular dementia

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 3, 2014, Pages 938-947

  Rohn, Troy T ^a   Day, Ryan J ^a   Sheffield, Colin B ^a   Rajic, Alexander J ^b   Poon, Wayne W ^b  

^a BOISE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ApoE; Apolipoprotein E; Astrocytes; Immunohistochemistry; Neurofibrillary tangles; PHF 1; Plaques; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E;

AGED; CHEMISTRY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MULTIINFARCT DEMENTIA; NEUROFIBRILLARY TANGLE; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; DEMENTIA, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLES;

EID: 84899577489     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jellinger KA. The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol 2007; 113: 349-388.
2. Jellinger KA. Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci 2013; 5: 17.
3. Grinberg LT and Heinsen H. Toward a pathological definition of vascular dementia. J Neurol Sci 2010; 299: 136-138.
4. Jellinger KA. The pathology of "vascular dementia": a critical update. J Alzheimers Dis 2008; 14: 107-123.
5. Staekenborg SS, van der Flier WM, van Straaten EC, Lane R, Barkhof F and Scheltens P. Neurological signs in relation to type of cerebrovascular disease in vascular dementia. Stroke 2008; 39: 317-322.
6. In't Veld BA, Ruitenberg A, Hofman A, Stricker BH and Breteler MM. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 2001; 22: 407-412.
7. Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y and Mayeux R. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 2002; 58: 1175-1181.
8. Reitz C, Tang MX, Luchsinger J and Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 2004; 61: 705-714.
9. Van Oijen M, de Jong FJ, Witteman JC, Hofman A, Koudstaal PJ and Breteler MM. Atherosclerosis and risk for dementia. Ann Neurol 2007; 61: 403-410.
10. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE and Breteler MM. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996; 39: 1392-1397.
11. Geroldi C, Frisoni GB, Paolisso G, Bandinelli S, Lamponi M, Abbatecola AM, Zanetti O, Guralnik JM and Ferrucci L. Insulin resistance in cognitive impairment: the InCHIANTI study. Arch Neurol 2005; 62: 1067-1072.
12. Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomilehto J, Winblad B, Sulkava R and Kivipelto M. Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology 2010; 75: 1195-1202.
13. Leys D, Henon H, Mackowiak-Cordoliani MA and Pasquier F. Poststroke dementia. Lancet Neurol 2005; 4: 752-759.
14. Aggarwal NT and Decarli C. Vascular dementia: emerging trends. Semin Neurol 2007; 27: 66-77.
15. Ross GW, Petrovitch H, White LR, Masaki KH, Li CY, Curb JD, Yano K, Rodriguez BL, Foley DJ, Blanchette PL and Havlik R. Characterization of risk factors for vascular dementia: the Honolulu-Asia Aging Study. Neurology 1999; 53: 337-343.
16. Weisgraber KH, Rall SC Jr and Mahley RW. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem 1981; 256: 9077-9083.
17. Eisenstein M. Genetics: finding risk factors. Nature 2011; 475: S20-22.
18. Rohn TT. Proteolytic cleavage of apolipoprotein e4 as the keystone for the heightened risk associated with Alzheimer's disease. Int J Mol Sci 2013; 14: 14908-14922.
19. Rohn TT, Catlin LW, Coonse KG and Habig JW. Identification of an amino-terminal fragment of apolipoprotein E4 that localizes to neurofibrillary tangles of the Alzheimer's disease brain. Brain Res 2012; 1475: 106-115.
20. Rohn TT and Catlin LW. Immunolocalization of influenza A virus and markers of inflammation in the human Parkinson's disease brain. PLoS One 2011; 6: e20495.
21. Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA and Mahley RW. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci U S A 2001; 98: 8838-8843.
22. Davidson Y, Gibbons L, Purandare N, Byrne J, Hardicre J, Wren J, Payton A, Pendleton N, Horan M, Burns A and Mann DM. Apolipoprotein E epsilon4 allele frequency in vascular dementia. Dement Geriatr Cogn Disord 2006; 22: 15-19.
23. Chuang YF, Hayden KM, Norton MC, Tschanz J, Breitner JC, Welsh-Bohmer KA and Zandi PP. Association between APOE epsilon4 allele and vascular dementia: The Cache County study. Dement Geriatr Cogn Disord 2010; 29: 248-253.
24. Kim KW, Youn JC, Han MK, Paik NJ, Lee TJ, Park JH, Lee SB, Choo IH, Lee DY, Jhoo JH and Woo JI. Lack of association between apolipoprotein E polymorphism and vascular dementia in Koreans. J Geriatr Psychiatry Neurol 2008; 21: 12-17.
25. Engelborghs S, Dermaut B, Goeman J, Saerens J, Marien P, Pickut BA, Van den Broeck M, Serneels S, Cruts M, Van Broeckhoven C and De Deyn PP. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. J Neurol Neurosurg Psychiatry 2003; 74: 1148-1151.
26. Moretti A, Gorini A and Villa RF. Pharmacotherapy and prevention of vascular dementia. CNS Neurol Disord Drug Targets 2011; 10: 370-390.
27. Rosenberg GA, Sullivan N and Esiri MM. White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke 2001; 32: 1162-1168.
28. Mann DM and Esiri MM. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci 1989; 89: 169-179.
29. Harris FM, Brecht WJ, Xu Q, Tesseur I, Kekonius L, Wyss-Coray T, Fish JD, Masliah E, Hopkins PC, Scearce-Levie K, Weisgraber KH, Mucke L, Mahley RW and Huang Y. Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci U S A 2003; 100: 10966-10971.